NCT03739060

Brief Summary

Lichtenstein herniorrhaphy still remains one of the most often performed inguinal hernia repair techniques. It is frequently associated with acute postoperative and chronic pain. Due to insufficient effect of non-steroidal anti-inflammatory drugs, they are often overdosed. However opioids have many side effects. Interventional treatment, such as transversus abdominis plain (TAP) block requires an additional intervention and has relatively short effect, also could not be applied in outpatient conditions. The hypoalgesic effect of transcutaneous electric nerve stimulation (TENS) is well known for many years, but effectiveness during postoperative period is still controversial and maybe therefore didn't come to daily practice. However it could be a promising part of multi-modal pain treatment for hernia patients. This study analyse the hypoalgesic effect of TENS and its impact on hernia specific quality of life (QoL) after Lichtenstein hernia repair. Aim#1 To determine whether use of TENS is effective for acute postoperative pain relief. Aim#2 To determine whether use of TENS have impact on hernia specific QoL in early and late postoperative period. Aim#3 To identify factors associated with effectiveness/ineffectiveness of TENS procedures. Aim#4 To determine whether a psychological condition (depression, anxiety and pain catastrophisation) is somehow associated with TENS effectiveness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2020

Completed
Last Updated

February 18, 2021

Status Verified

February 1, 2021

Enrollment Period

1.5 years

First QC Date

October 23, 2018

Last Update Submit

February 17, 2021

Conditions

Keywords

Inguinal herniaTranscutaneous electric nerve stimulationPostoperative painQuality of lifePain thresholdAlgometry

Outcome Measures

Primary Outcomes (1)

  • Change in pain level as assessed by the VAS.

    Pain is assessed using a 100 mm handheld slide rule-type visual analogue scale (VAS) with values from 0 to 100 (0 = no pain, 100 = extreme pain) during lying, waking and getting out of bed. Total scores are averaged.

    10 min before and 10 min after each TENS procedure, which occur 24, 26, 48 and 50 hours after surgery.

Secondary Outcomes (8)

  • Change in pressure pain threshold.

    1 hour before surgery (baseline), 10 min before and 10 min after each TENS procedure, which occur 24, 26, 48 and 50 hours after surgery.

  • Change in pressure pain tolerance.

    1 hour before surgery (baseline), 10 min before and 10 min after each TENS procedure, which occur 24, 26, 48 and 50 hours after surgery.

  • Change in hernia specific quality of life.

    1 hour before surgery (baseline), 2 days, 1 week, 4 weeks and 6 month after surgery.

  • Change in overall quality of life.

    1 hour before surgery (baseline), 2 days, 1 week, 4 weeks and 6 month after surgery.

  • Consumption of analgesic drugs.

    2 days postoperative

  • +3 more secondary outcomes

Study Arms (2)

Active TENS group

ACTIVE COMPARATOR

Conventional transcutaneous electric nerve stimulation

Device: Transcutaneous electric nerve stimulation

Placebo TENS group

PLACEBO COMPARATOR

0 amperes transcutaneous electric nerve stimulation

Device: Transcutaneous electric nerve stimulation

Interventions

Conventional transcutaneous electric nerve stimulation

Also known as: TENS
Active TENS groupPlacebo TENS group

Eligibility Criteria

Age18 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective Lichtenstein repair for primary hernia
  • Male gender
  • No TENS procedures in the past
  • American Society of Anesthesiologists physical status I or II
  • No cognitive, speaking, hearing or visual disturbances
  • No movement disorders

You may not qualify if:

  • Non Lithuanian speaker
  • Known allergy to a patch glue
  • Chronic use of non-steroidal anti inflammatory drugs or opioids
  • Neuropathic diseases
  • General contraindication for TENS procedures (such as skin disorders in site of electrodes application or pacemaker)
  • Not able to complete the questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lithuanian University of Health Sciences

Kaunas, LT44307, Lithuania

Location

Related Publications (1)

  • Parseliunas A, Paskauskas S, Kubiliute E, Vaitekunas J, Venskutonis D. Transcutaneous Electric Nerve Stimulation Reduces Acute Postoperative Pain and Analgesic Use After Open Inguinal Hernia Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial. J Pain. 2021 May;22(5):533-544. doi: 10.1016/j.jpain.2020.11.006. Epub 2020 Dec 10.

MeSH Terms

Conditions

Hernia, InguinalPain, Postoperative

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Audrius Paršeliūnas, MD

    Lithuanian University of Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 23, 2018

First Posted

November 13, 2018

Study Start

August 1, 2018

Primary Completion

February 8, 2020

Study Completion

July 8, 2020

Last Updated

February 18, 2021

Record last verified: 2021-02

Locations